The invention relates to treatment of cancer in a mammal who has undergone stem cell transplantation by administering an effective amount of a human anti-CTLA-4 antibody to the mammal. Stem cell transplantation may be allogeneic or autologous stem cell transplantation and may be preceded by a preparatory treatment such as chemotherapy. The methods of the invention may be combined with additional cancer treatments. Further, the invention relates to treatment of cancer using at least 10 mg/kg of a human anti-CTLA-4 antibody, and, more preferably, about 15-20 mg/kg of antibody.
申请公布号
WO2005092380(A3)
申请公布日期
2006.06.15
申请号
WO2005IB00671
申请日期
2005.03.14
申请人
PFIZER PRODUCTS INC;GOMEZ-NAVARRO, JESUS;HANSON, DOUGLAS, CHARLES;MUELLER, EILEEN, ELLIOTT;NOE, DENNIS, ALAN
发明人
GOMEZ-NAVARRO, JESUS;HANSON, DOUGLAS, CHARLES;MUELLER, EILEEN, ELLIOTT;NOE, DENNIS, ALAN